01.12.2015 | Research article | Ausgabe 1/2015 Open Access

Comorbidities, intensity, frequency and duration of pain, daily functioning and health care seeking in local, regional, and widespread pain—a descriptive population-based survey (SwePain)
- Zeitschrift:
- BMC Musculoskeletal Disorders > Ausgabe 1/2015
Electronic supplementary material
Competing interests
Authors’ contributions
Background
-
Are there differences regarding sociodemographics, comorbidities, general health, and physical activities between individuals with and without pain?
-
Is the spreading of pain (defined as LP, RP, and WSP) associated with co-morbidities, limitation of professional work and daily chores, limitation of physical activity, increased health care seeking behaviours as well as pain intensity, frequency, and duration?
-
What pattern of transition between the three pain categories (LP, RP, and WSP) can be seen over a short period?
Methods
Subjects and questionnaires
The three pain categories
Categorization of items on education level, general health, pain frequency, consequnecs for work and physical activities
Statistical analysis
Weighted data
Auxiliary variable
|
Non-weighted sample
|
Weighted sample
|
|
---|---|---|---|
N
|
Years
|
Years
|
|
Age
|
|||
25
th percentile
|
4744
|
41
|
29
|
50
th percentile
|
54
|
45
|
|
75
th percentile
|
64
|
62
|
|
N
|
%
|
%
|
|
Gender
|
|||
Men
|
2148
|
45
|
50
|
Women
|
2626
|
55
|
50
|
Country of birth
|
|||
Sweden
|
4191
|
88
|
84
|
EU 27 + Scandinavia (except Sweden)
|
192
|
4
|
4
|
Other countries
|
391
|
8
|
12
|
Educational level
|
|||
9-year compulsory school
|
1250
|
26
|
24
|
Upper secondary school
|
1988
|
42
|
43
|
University education
|
1482
|
31
|
33
|
Missing
|
54
|
1
|
1
|
Marital status
|
|||
Married
|
2467
|
52
|
42
|
Unmarried
|
2307
|
48
|
58
|
Municipality affiliation
|
|||
Urban area
|
4125
|
86
|
93
|
Rural area
|
649
|
14
|
7
|
Registered sick-leave more than 45 consecutive days in 2009
|
2134
|
45
|
1
|
Results
Response to postal questionnaire and prevalences of the three pain categories
Pain free subjects versus subjects with pain
n
p = 2983, n
np = 1491
|
Pain %
|
No pain %
|
Difference %
|
95 % CI
|
P-values
|
---|---|---|---|---|---|
Heart disease
|
11.0
|
6.7
|
4.3
|
2.53; 6.08
|
<0.001*
|
n
P =2466, n
np =1387
|
|||||
Hypertension
|
26.5
|
18.7
|
7.8
|
5.20; 10.34
|
<0.001*
|
n
p = 2715, n
np = 1488
|
|||||
Stroke
|
3.1
|
1.9
|
1.1
|
0.6; 1.7
|
0.019
|
n
p=2385, n
np = 1470
|
|||||
Diabetes
|
7.3
|
5.4
|
1.9
|
0.35; 3.45
|
<0.001*
|
n
p = 2441, n
np = 1474
|
|||||
Eczema
|
22.9
|
14.4
|
8.5
|
6.06; 1.7
|
<0.001*
|
n
p = 2492, n
np = 1489
|
|||||
Pulmonary disease
|
7.3
|
4.1
|
3.2
|
1.77; 4.63
|
<0.001*
|
n
p = 2442, n
np = 1460
|
|||||
Decreased general health
|
27.6
|
6.1
|
21.5
|
19.5; 23.5
|
<0.001*
|
n
p = 2963, n
np = 1407
|
|||||
Maximally 1 h weekly spent on demanding physical activities
|
41.7
|
34.5
|
7.2
|
5.8; 7.6
|
0.001*
|
n
p = 2967, n
np = 1409
|
|||||
Low educational level
|
72.2
|
62.1
|
10.1
|
7.28; 12.83
|
<0.001*
|
n
P = 2963, n
np = 1407
|
Social and educational levels in the three pain categories
Pain category Variables
|
Local pain (
n = 414–418)
|
Regional pain (
n = 2200–2203)
|
Widespread pain (
n = 244–245)
|
Statistics (
p-value)
|
---|---|---|---|---|
Women (%)
|
51.4
|
59.4
|
75.6
|
LP vs. RP: <0.001*
|
LP vs. WSP: <0.001*
|
||||
RP vs. WSP: <0.001*
|
||||
Married (%)
|
50.2
|
52.0
|
52.8
|
LP vs. RP: 0.490
|
LP vs. WSP: 0.818
|
||||
RP vs. WSP: 0.320
|
||||
Low education level (%)
|
69.6
|
70.8
|
82.4
|
LP vs. RP: 0.740
|
LP vs. WSP: <0.001*
|
||||
RP vs. WSP: < 0.001*
|
||||
Mean age (years (sd))
|
53.3 (16.1)
|
51.7 (15.0)
|
52.2 (11.2)
|
LP vs. RP: 0.005*
|
LP vs. WSP: 0.135
|
||||
RP vs. WSP: 0.161
|
Comorbidities and general health in the three pain categories
Pain category Variables
|
Local pain (
n = 330–417)
|
Regional pain (
n = 1785–2203)
|
Widespread pain (
n = 199–244)
|
Statistics (
p-value)
|
---|---|---|---|---|
Heart disease (%)
|
9.5
|
10.0
|
20.5
|
LP vs. RP: 0.770
|
LP vs. WSP: 0.001*
|
||||
RP vs. WSP: <0.001*
|
||||
Hypertension (%)
|
24.9
|
25.2
|
34.3
|
LP vs. RP: 0.617
|
LP vs. WSP: 0.013
|
||||
RP vs. WSP: <0.001*
|
||||
Stroke (%)
|
3.3
|
2.9
|
3.0
|
LP vs. RP: 0.940
|
LP vs. WSP: 0.850
|
||||
RP vs. WSP: 0.513
|
||||
Eczema (%)
|
5.8
|
7.3
|
5.6
|
LP vs. RP: 0.022
|
LP vs. WSP: 0.920
|
||||
RP vs. WSP: 0.358
|
||||
Diabetes (%)
|
18.1
|
23.7
|
37.0
|
LP vs. RP: 0.329
|
LP vs. WSP: <0.001*
|
||||
RP vs. WSP: 0.001*
|
||||
Pulmonary disease (%)
|
8.3
|
6.8
|
8.4
|
LP vs. RP: 0.320
|
LP vs. WSP: 0.960
|
||||
RP vs. WSP: 0.392
|
||||
Decreased general health (%)
|
14.4
|
27.2
|
70.3
|
LP vs. RP: 0.051
|
LP vs. WSP: <0.001*
|
||||
RP vs. WSP: <0.001*
|
Frequency, duration and initensity of pain in the three pain categories
Pain category Variables
|
Local pain (
n = 403–416)
|
Regional pain (
n = 2106–2173)
|
Widespread pain (
n = 241–244)
|
Statistics (
p-value)
|
---|---|---|---|---|
Pain very often or always (%)
|
51.1
|
63.3
|
99.9
|
LP vs. RP: <0.001*
|
LP vs. WSP: <0.001*
|
||||
RP vs. WSP: <0.001*
|
||||
Pain duration > 3 months (%)
|
60.1
|
68.6
|
92.4
|
LP vs. RP: 0.130
|
LP vs. WSP: <0.001*
|
||||
RP vs. WSP: <0.001*
|
||||
Pain intensity last 7 days (median; (1
st and 3
rd quartile))
b
|
4 (3, 6)
|
5 (3, 6)
|
7 (6,8)
|
LP vs. RP: <0.001*
|
LP vs. WSP: <0.001*
|
||||
RP vs. WSP: <0.001*
|
Daily functioning and health care seeking in the three pain categories
Pain category Variables
|
Local pain (
n = 400–417)
|
Regional pain (
n = 2261–2205)
|
Widespread pain (
n = 242–245)
|
Statistics (
p-value)
|
---|---|---|---|---|
Maximally 1 h weekly spent on demanding physical activities (%)
|
36.4
|
42.3
|
46.5
|
LP vs. RP: 0.025
|
LP vs. WSP: 0.001*
|
||||
RP vs. WSP: 0.321
|
||||
Impact on ability to work or to perform daily chores (%)
|
12.6
|
19.0
|
74.6
|
LP vs. RP: 0.002*
|
LP vs. WSP: <0.001*
|
||||
RP vs. WSP: <0.001*
|
||||
Complementary health care last 12 months (%)
|
19.5
|
19.4
|
21.7
|
LP vs. RP: 0.980
|
LP vs. WSP: 0.500
|
||||
RP vs. WSP: 0.390
|
||||
Health care previous 12 months (%)
|
37.1
|
40.5
|
81.5
|
LP vs. RP: 0.260
|
LP vs. WSP: <0.001*
|
||||
RP vs. WSP: <0.001*
|
||||
Hospitality and treatment from health care service (%)
|
8 (0–10)
|
7 (0–10)
|
6 (0–10)
|
LP vs. RP: 0.018
|
LP vs. WSP: <0.001*
|
||||
RP vs. WSP: 0.028
|
Transition between the three pain categories at 9-week follow-up
After 9 weeks →
|
Local pain
|
Regional pain
|
Wide spread pain
|
Column total
|
No pain previous 7 days
|
---|---|---|---|---|---|
At baseline↓
|
% (95 % CI)
|
% (95 % CI)
|
% (95 % CI)
|
%
|
% (95 % CI)
|
Local pain
n = 184
|
56 (48.5; 62.7)
|
44 (37.3; 51.5)
|
0 (0.0; 2.0)
|
100
|
13 (9.2; 18.5)
|
Regional pain
n = 1205
|
10 (8.2; 11.6)
|
88 (85.5; 89.2)
|
3 (1.9; 3.8)
|
100
|
7 (5.7; 8.5)
|
Widespread pain
n = 146
|
0 (0.0; 2.6)
|
36 (28.9; 44.4)
|
64 (55.6; 71.1)
|
100
|
1 (0.2; 4.1)
|
Discussion
-
Subjects with pain had lower educational levels, more comorbidities, decreased general health, and decreased physical activities than the pain-free subjects.
-
Differences in comorbidities, certain pain aspects, daily functioning and health care seeking in the three pain categories based on spreading of pain were found.
-
Low education, heart disease, hypertension, diabetes, decreased general health, increased medical consultation, high impact on work, and intense, frequent, and chronic pain were more frequent in WSP than in RP and LP.
-
Regarding impact of work and frequency and intensity of pain, RP was the intermediate group and LP was the least affected group.
-
There was no difference between LP and RP regarding education, general health, duration of pain, and health care consumption.
-
The proportion of women differed between the three pain categories; it was highest in WSP and lowest in LP. This difference was also the case for experience of hospitality and good treatment from health care: WSP rated this lowest and LP highest.
-
In the pain categories, proportions of married subjects, physical demanding activities, and complementary health care did not differ.
-
For both LP and WSP, a substantial transition to RP had occurred by the 9-week follow-up.